BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28143738)

  • 1. Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
    Liu Y; Zhao D; Qiu F; Zhang LL; Liu SK; Li YY; Liu MT; Wu D; Wang JX; Ding XQ; Liu YX; Dong CJ; Shao XQ; Yang BF; Chu WF
    Mol Ther; 2017 Mar; 25(3):666-678. PubMed ID: 28143738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs.
    Dai J; Hu Y; Niu Q; Song G; Wang H; Li S
    Life Sci; 2020 Jun; 251():117607. PubMed ID: 32240679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylation.
    Liu Y; Li D; Nie D; Liu SK; Qiu F; Liu MT; Li YY; Wang JX; Liu YX; Dong CJ; Wu D; Tian W; Yang J; Mu W; Li JT; Zhao D; Wang XF; Chu WF; Yang BF
    Oncotarget; 2017 Jul; 8(28):45447-45458. PubMed ID: 28525371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
    Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
    Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1-PML SUMOylation-peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) form a positive feedback loop to regulate cardiac fibrosis.
    Wu D; Huang D; Li LL; Ni P; Li XX; Wang B; Han YN; Shao XQ; Zhao D; Chu WF; Li BY
    J Cell Physiol; 2019 May; 234(5):6263-6273. PubMed ID: 30246389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
    Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
    J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
    PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein - ring finger protein 4 dependent pathway.
    Komaravelli N; Ansar M; Garofalo RP; Casola A
    Free Radic Biol Med; 2017 Dec; 113():494-504. PubMed ID: 29107745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of SUMO-1 with ginkgolic acid alleviates cardiac fibrosis induced by myocardial infarction in mice.
    Qiu F; Dong C; Liu Y; Shao X; Huang D; Han Y; Wang B; Liu Y; Huo R; Paulo P; Zhang ZR; Zhao D; Chu WF
    Toxicol Appl Pharmacol; 2018 Apr; 345():1-9. PubMed ID: 29524504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells.
    Jo S; Lee YL; Kim S; Lee H; Chung H
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1499-509. PubMed ID: 27030546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
    Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
    Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
    Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
    J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
    Hirano S; Udagawa O
    Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
    J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SUMO2/3 specific E3 ligase ZNF451-1 regulates PML stability.
    Koidl S; Eisenhardt N; Fatouros C; Droescher M; Chaugule VK; Pichler A
    Int J Biochem Cell Biol; 2016 Oct; 79():478-487. PubMed ID: 27343429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between PML and p53 in response to TGF-β1: A new mechanism of cardiac fibroblast activation.
    Huang D; Zhao D; Li M; Chang SY; Xue YD; Xu N; Li SJ; Tang NN; Gong LL; Liu YN; Yu H; Li QS; Li PY; Liu JL; Chen HX; Liu MB; Zhang WY; Zhao XM; Lang XZ; Li ZD; Liu Y; Ma ZY; Li JM; Wang N; Tian H; Cai BZ
    Int J Biol Sci; 2023; 19(3):994-1006. PubMed ID: 36778116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
    Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
    Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
    Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G
    Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.
    McManus FP; Bourdeau V; Acevedo M; Lopes-Paciencia S; Mignacca L; Lamoliatte F; Rojas Pino JW; Ferbeyre G; Thibault P
    Sci Rep; 2018 May; 8(1):7754. PubMed ID: 29773808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.